You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Quanterix, a Lexington company specializing in technology designed for the early detection of diseases, raises $18.5m

Quanterix, a Lexington company specializing in technology designed for the early detection of diseases, said Thursday that it has closed an $18.5 million Series C financing.

Quanterix added that it has also entered a strategic agreement with bioMerieux, a French company that plans to use Quanterix’s Simoa technology to develop specialized tests that focus on infectious diseases.

Continue reading below

As part of the financing, bioMerieux has taken an initial $15 million equity stake in Quanterix.

Participants in the Series C round include existing investors ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures as well as In-Q-Tel, Quanterix said.

Quanterix said it has raised $46.5 million to date.

The company added that its strategic agreement with bioMerieux gives its worldwide exclusive rights to Quanterix’s Simoa technology in clinical laboratories and for industrial applications.

Under the agreement, Quanterix is eligible to receive upfront and milestone payments as well as royalties on future sales. The agreement calls for bioMerieux to take an additional equity stake, contingent upon the achievement of the agreement’s milestones.

Chris Reidy can be reached at reidy@globe.com.
Loading comments...
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.